Atherosclerosis Signaling |
3.32E00 |
4.72E-02 |
CSF1, CXCR4, IL1F7, PRDX6, TNFRSF12A |
Macropinocytosis Signaling |
3.06E00 |
5.56E-02 |
ITGB1, CSF1, PIK3R5, ITGB4 |
Role of Osteoblasts, Osteoclasts and Chondrocytes in Rheumatoid Arthritis |
2.57E00 |
2.78E-02 |
ITGB1, CSF1, RUNX2, PIK3R5, IL1F7, BCL2 |
Aminosugars Metabolism |
2.05E00 |
4.69E-02 |
PDE8A, GM2A, HEXB |
Glycosphingolipid Biosynthesis - Globoseries |
1.92E00 |
8E-02 |
GM2A, HEXB |
N-Glycan Degradation |
1.8E00 |
6.9E-02 |
GM2A, HEXB |
HER-2 Signaling in Breast Cancer |
1.88E00 |
3.85E-02 |
ITGB1, PIK3R5, ITGB4 |
Reelin Signaling in Neurons |
1.86E00 |
3.85E-02 |
ITGB1, BLK, PIK3R5 |
Altered T Cell and B Cell Signaling in Rheumatoid Arthritis |
1.82E00 |
3.66E-02 |
CSF1, IL1F7, IL23A |
Melanocyte Development and Pigmentation Signaling |
1.77E00 |
3.57E-02 |
SOX10, PIK3R5, BCL2 |
Glycosphingolipid Biosynthesis - Ganglioseries |
1.74E00 |
6.45E-02 |
GM2A, HEXB |
Dendritic Cell Maturation |
1.73E00 |
2.52E-02 |
PIK3R5, IGHG1, IL1F7, IL23A |
Virus Entry via Endocytic Pathways |
1.72E00 |
3.41E-02 |
ITGB1, PIK3R5, ITGB4 |
PTEN Signaling |
1.66E00 |
3E-02 |
ITGB1, PIK3R5, BCL2 |
Glycosaminoglycan Degradation |
1.62E00 |
5.56E-02 |
GM2A, HEXB |
Glioma Signaling |
1.59E00 |
2.8E-02 |
E2F5, CAMK1G, PIK3R5 |
Docosahexaenoic Acid (DHA) Signaling |
1.58E00 |
5E-02 |
PIK3R5, BCL2 |
Pancreatic Adenocarcinoma Signaling |
1.51E00 |
2.7E-02 |
E2F5, PIK3R5, BCL2 |
Leukocyte Extravasation Signaling |
1.48E00 |
2.17E-02 |
ITGB1, ARHGAP6, CXCR4, PIK3R5 |
Integrin Signaling |
1.44E00 |
2.04E-02 |
ITGB1, PIK3R5, ITGB4, TTN |
Role of Cytokines in Mediating Communication between Immune Cells |
1.33E00 |
3.85E-02 |
IL1F7, IL23A |
Role of BRCA1 in DNA Damage Response |
1.27E00 |
3.45E-02 |
ATF1, E2F5 |